Business Wire

Sigfox Signs A Global Partnership With Skyhook To Improve Delivery of Geolocation Services

9.12.2021 18:00:00 EET | Business Wire | Press release

Share

Sigfox, a world’s leading IoT (Internet of Things) communication service provider and 0G network pioneer, has announced today its partnership with Skyhook, the leading independent provider of Wi-Fi, cellular, and hybrid positioning. The collaboration is set to improve the quality and performance of existing tracking services on the Sigfox network globally, while delivering enhanced customer experience at an accessible cost.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209005469/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

As part of its services, Skyhook offers Wi-Fi location solutions, which can be used on its own or as part of a larger hybrid positioning system. This software-based, power-efficient approach uses Wi-Fi, GPS/GNSS, and cellular signals to track location, and uses over 6 billion geolocated Wi-Fi access points, over 110 million geolocated cells, and 1.5 billion geolocated IP addresses for unmatched reliability and accuracy. Through its unique approach, Skyhook’s Precision Location solution is able to accurately locate connected devices anywhere in the world.

By integrating global coverage from Skyhook’s positioning services with Sigfox’s existing Atlas Wi-Fi service, companies will be able to locate their assets in indoor environments, where other positioning methods can fall short. Customers directly benefit from the integration of Skyhook services, removing the need for additional infrastructure, regardless of the size and quantity of assets.

Atlas Wi-Fi, Sigfox’s geolocation service for massive IoT applications is specifically optimized to support global supply chain and logistics applications and combines two technologies and data sources - the Sigfox network and Wi-Fi infrastructure. Accordingly, Sigfox can provide one single location service in all types of geographic environments, without GPS.

Additionally, as Wi-Fi-based location tracking consumes less battery than using GPS, this new partnership will help extend the service life of IoT tracking solutions, thus reducing maintenance costs.

Skyhook is proud to partner with Sigfox to ensure accurate location information is available regardless of whether an asset is inside a warehouse, outside in the lot or in transit. Integrating Skyhook’s technology into Sigfox’s global location platform is an important next step as Sigfox maintains its position as a recognized global leader in the IoT space,” said Craig Waggy, CEO of Skyhook.

This partnership with Skyhook will help our clients gain better visibility of their supply chains, and ultimately provide a better service to their end customers. Understanding the exact location of assets globally without the additional costs associated with new infrastructure will no doubt drive business efficiencies. We see major traction around postal, retail and automotive use cases and Skyhook will help us provide the right quality of services for these key customers,” added Benjamin Mazet, Asset Tracking Director at Sigfox.

******

About Sigfox
Sigfox is a world’s leading IoT (Internet of Things) communication service provider and 0G network pioneer. Sigfox offers a unique combination of ultra-low cost and ultra-low power solutions enabled by a single global network, owned and operated by 75 Sigfox Operators, enabling businesses to gain visibility and track their assets worldwide. With more than 19 million connected devices and 75 million messages sent a day, Sigfox helps its customers to extract data at the lowest cost of production and accelerate their digital transformation in key areas such as asset tracking and monitoring.

ISO 9001 certified and supported by a strong partner ecosystem, Sigfox was founded in 2010 and is headquartered in Labège, France, with offices in Boston, Dallas, Dubai, Madrid, Paris, Sao Paulo, Singapore, and Tokyo.

About Skyhook
Skyhook is the worldwide independent leader in location technology, operating the world's largest independent location network, consisting of over 6 billion geolocated Wi-Fi access points, over 110 million geolocated cells, and 1.5 billion geolocated IP addresses. Skyhook processes tens of billions of location transactions, serving devices, apps, wearables, brands and advertising platforms with precise and accurate location data and intelligence. Skyhook, through its parent company Skyhook Holding, Inc., operates as a wholly owned subsidiary of Liberty Broadband Corporation. To learn more visit www.skyhook.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press Contacts

S igfox
Antoine Mège, Corporate Communications
antoine.mege@sigfox.com

Skyhook
Isolde Decker-Lucke, Marketing Manager
idecker-lucke@skyhook.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release

The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 12:52:00 EEST | Press release

The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not merely a wage dispute. It stems from deep structural concerns regarding the company’s ESG management, lack of operational autonomy, and passive labor relations. Primarily, the union highlighted unresolved corporate governance issues, including allegations concerning unfair labor practices and the unauthorized use of employee personal data, which were prominently reported by South Korea's major broadcaster, MBC, in November 2025. The union believes this crisis stems from management's failure to address r

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye